83 results
Page 3 of 5
DEFA14A
9lfc1eu sp1n59
26 Nov 18
Additional proxy soliciting materials
9:00am
8-K
EX-99.1
68l773sgyraaod4
15 Nov 18
Akers Biosciences Announces Q3 2018 Earnings
7:00am
424B5
ifun lm8gkb
2 Nov 18
Prospectus supplement for primary offering
6:13am
8-K/A
EX-99.1
52veb2f7l6z79pd
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
8:15pm
8-K
EX-99.1
60chcxzgshj1i
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
4:30pm
8-K
EX-99.1
dyo5t0mg 267ygefizj
31 May 18
Akers Biosciences Granted 180-Day Extension by Nasdaq
8:21am
8-K
EX-99.1
rmchh0
25 May 18
Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
5:00pm
8-K
EX-99.1
wggp6e0biu8
26 Dec 17
Akers Biosciences Announces Closing of $6,900,000 Public Offering
12:00am
424B4
oyff6gm
20 Dec 17
Prospectus supplement with pricing info
12:00am